Clinical Trial Update: Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing letrozole with lerociclib versus letrozole with placebo in advanced/metastatic or recurrent endometrial cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)
• lerociclib (lerociclib)

Snippet

Sponsor: EQRx International, Inc. | Conditions: Endometrial Carcinoma | Phase 3 | Status: WITHDRAWN